Comparison of Mesenchymal Stem Cells from Different Tissues to Suppress T-Cell Activation
Open Access
- 1 May 2007
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 16 (5), 555-562
- https://doi.org/10.3727/000000007783464939
Abstract
Graft-versus-host disease (GvHD) and graft rejection have remained significant complications of allogeneic stem cell transplantation. Mesenchymal stem cells (MSCs) from the bone marrow have been shown to suppress T-cell activation in vitro and in vivo, and may be used to reduce GvHD in the recipient or to facilitate engraftment across MHC barriers. MSCs can be derived from a variety of tissues. Thus, we asked whether MSCs from different tissues might have differential effects on T-cell responses. We were particularly interested in MSCs derived from adipose tissue because of its abundance and accessibility. We investigated and compared the immunosuppressive potential of murine MSCs derived from muscle tissue, adipose tissue, omentum, and bone. Cells from the different tissues were enriched for MSCs and cultured for 2–3 weeks to deplete hematopoietic cells. Mixed lymphocyte reactions (MLRs) including MSCs were performed using concanavalin A or allogeneic T cells as inducers of T-cell activation. MSCs from all tissues differentiated into multiple lineages. Mitogen-induced T-cell activation, as well as allogeneic T-cell responses, was reduced in MLRs mediated by the addition of MSCs. Reduction of T-cell activation was most pronounced for muscle tissue in the mitogen-induced MLR and fat tissue during the allogeneic MLR. These data demonstrate that MSCs from multiple tissues efficiently reduce T-cell activation. The results suggest that MSCs from adipose tissue can serve as an alternative source for MSCs to bone or bone marrow for the modulation of GvHD after allogeneic stem cell transplantation or to enhance engraftment across MHC barriers.Keywords
This publication has 31 references indexed in Scilit:
- Human bone marrow adipocytes support complete myeloid and lymphoid differentiation from human CD34+ cellsBritish Journal of Haematology, 2004
- Allogeneic bone marrow–derived flk-1+Sca-1− mesenchymal stem cells leads to stable mixed chimerism and donor-specific toleranceExperimental Hematology, 2004
- Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animalsBlood, 2003
- Low Risk of Graft-Versus-Host Disease With Transplantation of CD34 Selected Peripheral Blood Progenitor Cells From Alternative Donors for Fanconi AnemiaJournal of Pediatric Hematology/Oncology, 2003
- Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selectionJournal of Cellular Biochemistry, 2003
- Comparative study of stromal cell lines derived from embryonic, fetal, and postnatal mouse blood-forming tissuesExperimental Hematology, 2002
- Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuliBlood, 2002
- Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivoExperimental Hematology, 2002
- Multilineage differentiation activity by cells isolated from umbilical cord blood: Expression of bone, fat, and neural markersTransplantation and Cellular Therapy, 2001
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998